nodes	percent_of_prediction	percent_of_DWPC	metapath
Teniposide—Etoposide—peripheral nervous system neoplasm	0.284	1	CrCtD
Teniposide—Podofilox—Etoposide—peripheral nervous system neoplasm	0.161	1	CrCrCtD
Teniposide—Topoisomerase Inhibitors—Topotecan—peripheral nervous system neoplasm	0.144	0.392	CiPCiCtD
Teniposide—Topoisomerase Inhibitors—Etoposide—peripheral nervous system neoplasm	0.0961	0.262	CiPCiCtD
Teniposide—Topoisomerase Inhibitors—Epirubicin—peripheral nervous system neoplasm	0.0661	0.18	CiPCiCtD
Teniposide—Topoisomerase Inhibitors—Doxorubicin—peripheral nervous system neoplasm	0.0612	0.167	CiPCiCtD
Teniposide—ABCC6—Dactinomycin—peripheral nervous system neoplasm	0.0292	0.203	CbGbCtD
Teniposide—ABCC6—Cisplatin—peripheral nervous system neoplasm	0.0168	0.117	CbGbCtD
Teniposide—ABCC6—Etoposide—peripheral nervous system neoplasm	0.0165	0.115	CbGbCtD
Teniposide—TOP2A—Epirubicin—peripheral nervous system neoplasm	0.0113	0.0783	CbGbCtD
Teniposide—ABCC6—Doxorubicin—peripheral nervous system neoplasm	0.0112	0.0782	CbGbCtD
Teniposide—TOP2A—Etoposide—peripheral nervous system neoplasm	0.00878	0.061	CbGbCtD
Teniposide—ABCG2—Topotecan—peripheral nervous system neoplasm	0.00832	0.0579	CbGbCtD
Teniposide—TOP2A—Doxorubicin—peripheral nervous system neoplasm	0.00599	0.0416	CbGbCtD
Teniposide—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.00577	0.0401	CbGbCtD
Teniposide—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.00429	0.0298	CbGbCtD
Teniposide—ABCG2—Vincristine—peripheral nervous system neoplasm	0.00355	0.0247	CbGbCtD
Teniposide—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.00331	0.023	CbGbCtD
Teniposide—ABCG2—Etoposide—peripheral nervous system neoplasm	0.00326	0.0226	CbGbCtD
Teniposide—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.00287	0.02	CbGbCtD
Teniposide—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.00222	0.0154	CbGbCtD
Teniposide—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.00197	0.0137	CbGbCtD
Teniposide—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0018	0.0125	CbGbCtD
Teniposide—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0018	0.0125	CbGbCtD
Teniposide—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00167	0.0116	CbGbCtD
Teniposide—NCOA3—Validated nuclear estrogen receptor beta network—SMARCB1—peripheral nervous system neoplasm	0.00127	0.117	CbGpPWpGaD
Teniposide—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00123	0.00856	CbGbCtD
Teniposide—NCOA1—Validated nuclear estrogen receptor beta network—SMARCB1—peripheral nervous system neoplasm	0.00105	0.0966	CbGpPWpGaD
Teniposide—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.000767	0.00534	CbGbCtD
Teniposide—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.000703	0.00489	CbGbCtD
Teniposide—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00048	0.00334	CbGbCtD
Teniposide—NCOA3—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.000464	0.46	CbGdCrCtD
Teniposide—NCOA1—IL-6 signaling pathway—VIP—peripheral nervous system neoplasm	0.000358	0.0329	CbGpPWpGaD
Teniposide—ABCG2—Abacavir transmembrane transport—ABCB1—peripheral nervous system neoplasm	0.000329	0.0302	CbGpPWpGaD
Teniposide—ABCC6—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	0.00029	0.0267	CbGpPWpGaD
Teniposide—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	0.000251	0.0231	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—BARD1—peripheral nervous system neoplasm	0.000246	0.0226	CbGpPWpGaD
Teniposide—NCOA1—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000231	0.0212	CbGpPWpGaD
Teniposide—NCOA1—Orphan transporters—COX2—peripheral nervous system neoplasm	0.000215	0.0198	CbGpPWpGaD
Teniposide—NCOA1—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	0.000208	0.0191	CbGpPWpGaD
Teniposide—ABCG2—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000192	0.0176	CbGpPWpGaD
Teniposide—ABCG2—Abacavir transport and metabolism—ABCB1—peripheral nervous system neoplasm	0.000189	0.0174	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—COX2—peripheral nervous system neoplasm	0.000182	0.0168	CbGpPWpGaD
Teniposide—TOP2A—Gastric Cancer Network 1—AURKA—peripheral nervous system neoplasm	0.00018	0.0166	CbGpPWpGaD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—BARD1—peripheral nervous system neoplasm	0.000168	0.0154	CbGpPWpGaD
Teniposide—NCOA1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000164	0.015	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	0.000152	0.014	CbGpPWpGaD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—IFNB1—peripheral nervous system neoplasm	0.000138	0.0127	CbGpPWpGaD
Teniposide—CYP3A5—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000137	0.0126	CbGpPWpGaD
Teniposide—ABCC6—Podofilox—Etoposide—peripheral nervous system neoplasm	0.000132	0.131	CbGdCrCtD
Teniposide—NCOA1—HIF-1-alpha transcription factor network—ABCB1—peripheral nervous system neoplasm	0.000129	0.0119	CbGpPWpGaD
Teniposide—NCOA1—IL-6 signaling pathway—PTPN11—peripheral nervous system neoplasm	0.000129	0.0119	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	0.00011	0.0101	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—AURKA—peripheral nervous system neoplasm	0.000104	0.00954	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000102	0.00941	CbGpPWpGaD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.0001	0.00919	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	9.82e-05	0.00902	CbGpPWpGaD
Teniposide—Etoposide—ABCB1—peripheral nervous system neoplasm	9.61e-05	1	CrCbGaD
Teniposide—NCOA3—Idarubicin—Epirubicin—peripheral nervous system neoplasm	9.07e-05	0.0899	CbGdCrCtD
Teniposide—ABCG2—HIF-2-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	8.99e-05	0.00826	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—CNTN6—peripheral nervous system neoplasm	8.48e-05	0.00779	CbGpPWpGaD
Teniposide—NCOA3—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	8.39e-05	0.0832	CbGdCrCtD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	8.28e-05	0.0076	CbGpPWpGaD
Teniposide—NCOA1—Leptin signaling pathway—PTPN11—peripheral nervous system neoplasm	8.27e-05	0.00759	CbGpPWpGaD
Teniposide—NCOA3—Retinoic acid receptors-mediated signaling—AKT1—peripheral nervous system neoplasm	8.08e-05	0.00742	CbGpPWpGaD
Teniposide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	7.52e-05	0.00691	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	7.28e-05	0.00669	CbGpPWpGaD
Teniposide—ABCC6—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	7.26e-05	0.00667	CbGpPWpGaD
Teniposide—NCOA1—Retinoic acid receptors-mediated signaling—AKT1—peripheral nervous system neoplasm	6.68e-05	0.00614	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.6e-05	0.00606	CbGpPWpGaD
Teniposide—NCOA1—Leptin signaling pathway—ERBB2—peripheral nervous system neoplasm	6.53e-05	0.006	CbGpPWpGaD
Teniposide—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	6.38e-05	0.00586	CbGpPWpGaD
Teniposide—TOP2A—Irinotecan—Topotecan—peripheral nervous system neoplasm	6.38e-05	0.0632	CbGdCrCtD
Teniposide—NCOA3—Validated nuclear estrogen receptor alpha network—MYC—peripheral nervous system neoplasm	6.36e-05	0.00584	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.46e-05	0.00501	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—PTPN11—peripheral nervous system neoplasm	5.4e-05	0.00496	CbGpPWpGaD
Teniposide—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	5.34e-05	0.0049	CbGpPWpGaD
Teniposide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—peripheral nervous system neoplasm	5.3e-05	0.00487	CbGpPWpGaD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	5.29e-05	0.00486	CbGpPWpGaD
Teniposide—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—peripheral nervous system neoplasm	5.26e-05	0.00483	CbGpPWpGaD
Teniposide—NCOA1—Validated nuclear estrogen receptor alpha network—MYC—peripheral nervous system neoplasm	5.26e-05	0.00483	CbGpPWpGaD
Teniposide—NCOA1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.25e-05	0.00482	CbGpPWpGaD
Teniposide—NCOA1—IL-6 signaling pathway—AKT1—peripheral nervous system neoplasm	5.01e-05	0.0046	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—NCAM1—peripheral nervous system neoplasm	5.01e-05	0.0046	CbGpPWpGaD
Teniposide—TOP2A—Gastric Cancer Network 2—MYC—peripheral nervous system neoplasm	4.98e-05	0.00457	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—EED—peripheral nervous system neoplasm	4.74e-05	0.00436	CbGpPWpGaD
Teniposide—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	4.48e-05	0.00139	CcSEcCtD
Teniposide—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	4.48e-05	0.00139	CcSEcCtD
Teniposide—Oedema—Dactinomycin—peripheral nervous system neoplasm	4.47e-05	0.00139	CcSEcCtD
Teniposide—NCOA3—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.46e-05	0.00409	CbGpPWpGaD
Teniposide—Infection—Dactinomycin—peripheral nervous system neoplasm	4.45e-05	0.00138	CcSEcCtD
Teniposide—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	4.44e-05	0.00138	CcSEcCtD
Teniposide—Neuropathy—Doxorubicin—peripheral nervous system neoplasm	4.42e-05	0.00137	CcSEcCtD
Teniposide—Sepsis—Epirubicin—peripheral nervous system neoplasm	4.42e-05	0.00137	CcSEcCtD
Teniposide—Alopecia—Cisplatin—peripheral nervous system neoplasm	4.4e-05	0.00137	CcSEcCtD
Teniposide—Hypertension—Alitretinoin—peripheral nervous system neoplasm	4.39e-05	0.00137	CcSEcCtD
Teniposide—Leukopenia—Vincristine—peripheral nervous system neoplasm	4.38e-05	0.00136	CcSEcCtD
Teniposide—Urticaria—Topotecan—peripheral nervous system neoplasm	4.38e-05	0.00136	CcSEcCtD
Teniposide—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	4.38e-05	0.00136	CcSEcCtD
Teniposide—Abdominal pain—Topotecan—peripheral nervous system neoplasm	4.36e-05	0.00136	CcSEcCtD
Teniposide—Body temperature increased—Topotecan—peripheral nervous system neoplasm	4.36e-05	0.00136	CcSEcCtD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—MYC—peripheral nervous system neoplasm	4.35e-05	0.004	CbGpPWpGaD
Teniposide—Urticaria—Tretinoin—peripheral nervous system neoplasm	4.35e-05	0.00135	CcSEcCtD
Teniposide—Urticaria—Isotretinoin—peripheral nervous system neoplasm	4.35e-05	0.00135	CcSEcCtD
Teniposide—Chest pain—Alitretinoin—peripheral nervous system neoplasm	4.33e-05	0.00135	CcSEcCtD
Teniposide—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	4.33e-05	0.00135	CcSEcCtD
Teniposide—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	4.33e-05	0.00135	CcSEcCtD
Teniposide—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	4.33e-05	0.00135	CcSEcCtD
Teniposide—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	4.33e-05	0.00135	CcSEcCtD
Teniposide—Urticaria—Melphalan—peripheral nervous system neoplasm	4.29e-05	0.00134	CcSEcCtD
Teniposide—Phlebitis—Epirubicin—peripheral nervous system neoplasm	4.29e-05	0.00133	CcSEcCtD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—ERBB2—peripheral nervous system neoplasm	4.27e-05	0.00392	CbGpPWpGaD
Teniposide—Anorexia—Dactinomycin—peripheral nervous system neoplasm	4.27e-05	0.00133	CcSEcCtD
Teniposide—Neoplasm—Doxorubicin—peripheral nervous system neoplasm	4.26e-05	0.00132	CcSEcCtD
Teniposide—Flushing—Etoposide—peripheral nervous system neoplasm	4.23e-05	0.00132	CcSEcCtD
Teniposide—Hypertension—Vincristine—peripheral nervous system neoplasm	4.23e-05	0.00132	CcSEcCtD
Teniposide—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	4.23e-05	0.00131	CcSEcCtD
Teniposide—Confusional state—Alitretinoin—peripheral nervous system neoplasm	4.18e-05	0.0013	CcSEcCtD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—ABCB1—peripheral nervous system neoplasm	4.17e-05	0.00383	CbGpPWpGaD
Teniposide—Oedema—Alitretinoin—peripheral nervous system neoplasm	4.15e-05	0.00129	CcSEcCtD
Teniposide—NCOA1—Developmental Biology—NCAM1—peripheral nervous system neoplasm	4.14e-05	0.0038	CbGpPWpGaD
Teniposide—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	4.13e-05	0.00379	CbGpPWpGaD
Teniposide—Infection—Alitretinoin—peripheral nervous system neoplasm	4.12e-05	0.00128	CcSEcCtD
Teniposide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	4.12e-05	0.00378	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	4.1e-05	0.00376	CbGpPWpGaD
Teniposide—Chills—Etoposide—peripheral nervous system neoplasm	4.09e-05	0.00127	CcSEcCtD
Teniposide—TOP2A—Gastric Cancer Network 2—TP53—peripheral nervous system neoplasm	4.09e-05	0.00375	CbGpPWpGaD
Teniposide—Sepsis—Doxorubicin—peripheral nervous system neoplasm	4.09e-05	0.00127	CcSEcCtD
Teniposide—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	4.07e-05	0.00126	CcSEcCtD
Teniposide—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	4.06e-05	0.00126	CcSEcCtD
Teniposide—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	4.05e-05	0.00126	CcSEcCtD
Teniposide—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	4.03e-05	0.00125	CcSEcCtD
Teniposide—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	4.03e-05	0.00125	CcSEcCtD
Teniposide—Alopecia—Etoposide—peripheral nervous system neoplasm	4.03e-05	0.00125	CcSEcCtD
Teniposide—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	4.01e-05	0.00125	CcSEcCtD
Teniposide—Anaemia—Cisplatin—peripheral nervous system neoplasm	4e-05	0.00125	CcSEcCtD
Teniposide—Oedema—Vincristine—peripheral nervous system neoplasm	4e-05	0.00124	CcSEcCtD
Teniposide—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	3.98e-05	0.00124	CcSEcCtD
Teniposide—Infection—Vincristine—peripheral nervous system neoplasm	3.97e-05	0.00124	CcSEcCtD
Teniposide—Phlebitis—Doxorubicin—peripheral nervous system neoplasm	3.97e-05	0.00123	CcSEcCtD
Teniposide—Asthenia—Topotecan—peripheral nervous system neoplasm	3.96e-05	0.00123	CcSEcCtD
Teniposide—Anorexia—Alitretinoin—peripheral nervous system neoplasm	3.95e-05	0.00123	CcSEcCtD
Teniposide—Asthenia—Isotretinoin—peripheral nervous system neoplasm	3.93e-05	0.00122	CcSEcCtD
Teniposide—Asthenia—Tretinoin—peripheral nervous system neoplasm	3.93e-05	0.00122	CcSEcCtD
Teniposide—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	3.91e-05	0.00122	CcSEcCtD
Teniposide—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	3.91e-05	0.00122	CcSEcCtD
Teniposide—Pruritus—Topotecan—peripheral nervous system neoplasm	3.9e-05	0.00121	CcSEcCtD
Teniposide—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	3.89e-05	0.00121	CcSEcCtD
Teniposide—Leukopenia—Cisplatin—peripheral nervous system neoplasm	3.88e-05	0.00121	CcSEcCtD
Teniposide—Asthenia—Melphalan—peripheral nervous system neoplasm	3.88e-05	0.00121	CcSEcCtD
Teniposide—Hypotension—Alitretinoin—peripheral nervous system neoplasm	3.88e-05	0.00121	CcSEcCtD
Teniposide—Pruritus—Isotretinoin—peripheral nervous system neoplasm	3.87e-05	0.0012	CcSEcCtD
Teniposide—Pruritus—Tretinoin—peripheral nervous system neoplasm	3.87e-05	0.0012	CcSEcCtD
Teniposide—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	3.86e-05	0.0012	CcSEcCtD
Teniposide—ABCC6—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.84e-05	0.00353	CbGpPWpGaD
Teniposide—Pruritus—Melphalan—peripheral nervous system neoplasm	3.82e-05	0.00119	CcSEcCtD
Teniposide—Anorexia—Vincristine—peripheral nervous system neoplasm	3.81e-05	0.00119	CcSEcCtD
Teniposide—NCOA1—Gene Expression—SUZ12—peripheral nervous system neoplasm	3.79e-05	0.00348	CbGpPWpGaD
Teniposide—TOP2A—Vindesine—Vincristine—peripheral nervous system neoplasm	3.79e-05	0.0376	CbGdCrCtD
Teniposide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	3.78e-05	0.00117	CcSEcCtD
Teniposide—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	3.76e-05	0.00346	CbGpPWpGaD
Teniposide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	3.75e-05	0.00117	CcSEcCtD
Teniposide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	3.75e-05	0.00117	CcSEcCtD
Teniposide—Hypotension—Vincristine—peripheral nervous system neoplasm	3.74e-05	0.00116	CcSEcCtD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.7e-05	0.0034	CbGpPWpGaD
Teniposide—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	3.7e-05	0.00115	CcSEcCtD
Teniposide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	3.7e-05	0.00115	CcSEcCtD
Teniposide—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	3.69e-05	0.00115	CcSEcCtD
Teniposide—NCOA1—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.69e-05	0.00339	CbGpPWpGaD
Teniposide—Anaemia—Etoposide—peripheral nervous system neoplasm	3.67e-05	0.00114	CcSEcCtD
Teniposide—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	3.66e-05	0.00114	CcSEcCtD
Teniposide—NCOA1—Leptin signaling pathway—HRAS—peripheral nervous system neoplasm	3.64e-05	0.00334	CbGpPWpGaD
Teniposide—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	3.61e-05	0.00112	CcSEcCtD
Teniposide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	3.58e-05	0.00329	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	3.57e-05	0.00328	CbGpPWpGaD
Teniposide—NCOA1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	3.56e-05	0.00327	CbGpPWpGaD
Teniposide—Leukopenia—Etoposide—peripheral nervous system neoplasm	3.55e-05	0.0011	CcSEcCtD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—TP53—peripheral nervous system neoplasm	3.54e-05	0.00325	CbGpPWpGaD
Teniposide—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	3.54e-05	0.0011	CcSEcCtD
Teniposide—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	3.54e-05	0.0011	CcSEcCtD
Teniposide—Oedema—Cisplatin—peripheral nervous system neoplasm	3.53e-05	0.0011	CcSEcCtD
Teniposide—Infection—Cisplatin—peripheral nervous system neoplasm	3.51e-05	0.00109	CcSEcCtD
Teniposide—TOP2A—Circadian rythm related genes—TH—peripheral nervous system neoplasm	3.51e-05	0.00322	CbGpPWpGaD
Teniposide—Vomiting—Topotecan—peripheral nervous system neoplasm	3.51e-05	0.00109	CcSEcCtD
Teniposide—Vomiting—Tretinoin—peripheral nervous system neoplasm	3.48e-05	0.00108	CcSEcCtD
Teniposide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	3.48e-05	0.00108	CcSEcCtD
Teniposide—Rash—Topotecan—peripheral nervous system neoplasm	3.48e-05	0.00108	CcSEcCtD
Teniposide—Dermatitis—Topotecan—peripheral nervous system neoplasm	3.48e-05	0.00108	CcSEcCtD
Teniposide—Decreased appetite—Vincristine—peripheral nervous system neoplasm	3.48e-05	0.00108	CcSEcCtD
Teniposide—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	3.46e-05	0.00108	CcSEcCtD
Teniposide—Headache—Topotecan—peripheral nervous system neoplasm	3.46e-05	0.00108	CcSEcCtD
Teniposide—Rash—Isotretinoin—peripheral nervous system neoplasm	3.45e-05	0.00107	CcSEcCtD
Teniposide—Rash—Tretinoin—peripheral nervous system neoplasm	3.45e-05	0.00107	CcSEcCtD
Teniposide—Tachycardia—Cisplatin—peripheral nervous system neoplasm	3.45e-05	0.00107	CcSEcCtD
Teniposide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	3.45e-05	0.00107	CcSEcCtD
Teniposide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	3.45e-05	0.00107	CcSEcCtD
Teniposide—Vomiting—Melphalan—peripheral nervous system neoplasm	3.44e-05	0.00107	CcSEcCtD
Teniposide—Headache—Tretinoin—peripheral nervous system neoplasm	3.43e-05	0.00107	CcSEcCtD
Teniposide—Headache—Isotretinoin—peripheral nervous system neoplasm	3.43e-05	0.00107	CcSEcCtD
Teniposide—Hypertension—Etoposide—peripheral nervous system neoplasm	3.43e-05	0.00107	CcSEcCtD
Teniposide—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	3.42e-05	0.00106	CcSEcCtD
Teniposide—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	3.42e-05	0.00106	CcSEcCtD
Teniposide—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	3.41e-05	0.00106	CcSEcCtD
Teniposide—Rash—Melphalan—peripheral nervous system neoplasm	3.41e-05	0.00106	CcSEcCtD
Teniposide—Dermatitis—Melphalan—peripheral nervous system neoplasm	3.4e-05	0.00106	CcSEcCtD
Teniposide—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	3.39e-05	0.00106	CcSEcCtD
Teniposide—NCOA3—Androgen receptor signaling pathway—AKT1—peripheral nervous system neoplasm	3.39e-05	0.00311	CbGpPWpGaD
Teniposide—Chest pain—Etoposide—peripheral nervous system neoplasm	3.38e-05	0.00105	CcSEcCtD
Teniposide—Anorexia—Cisplatin—peripheral nervous system neoplasm	3.37e-05	0.00105	CcSEcCtD
Teniposide—Hypotension—Cisplatin—peripheral nervous system neoplasm	3.3e-05	0.00103	CcSEcCtD
Teniposide—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	3.3e-05	0.00103	CcSEcCtD
Teniposide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	3.3e-05	0.00103	CcSEcCtD
Teniposide—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	3.28e-05	0.00102	CcSEcCtD
Teniposide—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	3.28e-05	0.00102	CcSEcCtD
Teniposide—Nausea—Topotecan—peripheral nervous system neoplasm	3.28e-05	0.00102	CcSEcCtD
Teniposide—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	3.27e-05	0.00102	CcSEcCtD
Teniposide—Confusional state—Etoposide—peripheral nervous system neoplasm	3.27e-05	0.00102	CcSEcCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	3.25e-05	0.00299	CbGpPWpGaD
Teniposide—Nausea—Isotretinoin—peripheral nervous system neoplasm	3.25e-05	0.00101	CcSEcCtD
Teniposide—Nausea—Tretinoin—peripheral nervous system neoplasm	3.25e-05	0.00101	CcSEcCtD
Teniposide—NCOA3—Metabolism—GNS—peripheral nervous system neoplasm	3.22e-05	0.00296	CbGpPWpGaD
Teniposide—Infection—Etoposide—peripheral nervous system neoplasm	3.22e-05	0.001	CcSEcCtD
Teniposide—NCOA1—Leptin signaling pathway—AKT1—peripheral nervous system neoplasm	3.21e-05	0.00295	CbGpPWpGaD
Teniposide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	3.21e-05	0.000999	CcSEcCtD
Teniposide—Nausea—Melphalan—peripheral nervous system neoplasm	3.21e-05	0.000998	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	3.2e-05	0.00294	CbGpPWpGaD
Teniposide—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	3.17e-05	0.000986	CcSEcCtD
Teniposide—Tachycardia—Etoposide—peripheral nervous system neoplasm	3.16e-05	0.000983	CcSEcCtD
Teniposide—Body temperature increased—Vincristine—peripheral nervous system neoplasm	3.16e-05	0.000983	CcSEcCtD
Teniposide—Abdominal pain—Vincristine—peripheral nervous system neoplasm	3.16e-05	0.000983	CcSEcCtD
Teniposide—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	3.16e-05	0.000981	CcSEcCtD
Teniposide—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	3.15e-05	0.00098	CcSEcCtD
Teniposide—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	3.13e-05	0.000974	CcSEcCtD
Teniposide—TOP2A—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	3.12e-05	0.00287	CbGpPWpGaD
Teniposide—ABCC6—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.09e-05	0.00284	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—NME1—peripheral nervous system neoplasm	3.09e-05	0.00284	CbGpPWpGaD
Teniposide—Anorexia—Etoposide—peripheral nervous system neoplasm	3.09e-05	0.00096	CcSEcCtD
Teniposide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	3.07e-05	0.000956	CcSEcCtD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.06e-05	0.00281	CbGpPWpGaD
Teniposide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	3.06e-05	0.000952	CcSEcCtD
Teniposide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	3.06e-05	0.000951	CcSEcCtD
Teniposide—ABCC6—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.03e-05	0.00279	CbGpPWpGaD
Teniposide—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	3.03e-05	0.000943	CcSEcCtD
Teniposide—Hypotension—Etoposide—peripheral nervous system neoplasm	3.03e-05	0.000941	CcSEcCtD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—AKT1—peripheral nervous system neoplasm	3.02e-05	0.00277	CbGpPWpGaD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—AKT1—peripheral nervous system neoplasm	2.99e-05	0.00275	CbGpPWpGaD
Teniposide—Neutropenia—Epirubicin—peripheral nervous system neoplasm	2.99e-05	0.000928	CcSEcCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	2.98e-05	0.00274	CbGpPWpGaD
Teniposide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	2.98e-05	0.000926	CcSEcCtD
Teniposide—NCOA3—Metabolism—COX2—peripheral nervous system neoplasm	2.97e-05	0.00273	CbGpPWpGaD
Teniposide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	2.95e-05	0.000916	CcSEcCtD
Teniposide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	2.94e-05	0.000913	CcSEcCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	2.93e-05	0.00269	CbGpPWpGaD
Teniposide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	2.91e-05	0.000906	CcSEcCtD
Teniposide—Dyspnoea—Etoposide—peripheral nervous system neoplasm	2.89e-05	0.000898	CcSEcCtD
Teniposide—Asthenia—Vincristine—peripheral nervous system neoplasm	2.87e-05	0.000892	CcSEcCtD
Teniposide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	2.84e-05	0.000885	CcSEcCtD
Teniposide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	2.84e-05	0.000883	CcSEcCtD
Teniposide—Rash—Dactinomycin—peripheral nervous system neoplasm	2.82e-05	0.000878	CcSEcCtD
Teniposide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	2.82e-05	0.000876	CcSEcCtD
Teniposide—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	2.81e-05	0.000872	CcSEcCtD
Teniposide—NCOA1—Androgen receptor signaling pathway—AKT1—peripheral nervous system neoplasm	2.8e-05	0.00257	CbGpPWpGaD
Teniposide—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	2.79e-05	0.000869	CcSEcCtD
Teniposide—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	2.79e-05	0.000868	CcSEcCtD
Teniposide—NCOA1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.78e-05	0.00255	CbGpPWpGaD
Teniposide—Stomatitis—Epirubicin—peripheral nervous system neoplasm	2.77e-05	0.000863	CcSEcCtD
Teniposide—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	2.76e-05	0.000859	CcSEcCtD
Teniposide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	2.74e-05	0.000851	CcSEcCtD
Teniposide—Sweating—Epirubicin—peripheral nervous system neoplasm	2.73e-05	0.000849	CcSEcCtD
Teniposide—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	2.67e-05	0.00083	CcSEcCtD
Teniposide—NCOA1—Metabolism—GNS—peripheral nervous system neoplasm	2.67e-05	0.00245	CbGpPWpGaD
Teniposide—Nausea—Dactinomycin—peripheral nervous system neoplasm	2.66e-05	0.000827	CcSEcCtD
Teniposide—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	2.65e-05	0.000824	CcSEcCtD
Teniposide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	2.64e-05	0.00082	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	2.63e-05	0.00241	CbGpPWpGaD
Teniposide—Rash—Alitretinoin—peripheral nervous system neoplasm	2.62e-05	0.000814	CcSEcCtD
Teniposide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	2.61e-05	0.000813	CcSEcCtD
Teniposide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	2.6e-05	0.00081	CcSEcCtD
Teniposide—Headache—Alitretinoin—peripheral nervous system neoplasm	2.6e-05	0.000808	CcSEcCtD
Teniposide—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	2.58e-05	0.000803	CcSEcCtD
Teniposide—Urticaria—Etoposide—peripheral nervous system neoplasm	2.57e-05	0.0008	CcSEcCtD
Teniposide—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	2.57e-05	0.000799	CcSEcCtD
Teniposide—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	2.57e-05	0.000798	CcSEcCtD
Teniposide—Abdominal pain—Etoposide—peripheral nervous system neoplasm	2.56e-05	0.000796	CcSEcCtD
Teniposide—Body temperature increased—Etoposide—peripheral nervous system neoplasm	2.56e-05	0.000796	CcSEcCtD
Teniposide—NCOA1—Metabolism—NME1—peripheral nervous system neoplasm	2.56e-05	0.00235	CbGpPWpGaD
Teniposide—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	2.56e-05	0.000795	CcSEcCtD
Teniposide—Vomiting—Vincristine—peripheral nervous system neoplasm	2.54e-05	0.000791	CcSEcCtD
Teniposide—Asthenia—Cisplatin—peripheral nervous system neoplasm	2.54e-05	0.000789	CcSEcCtD
Teniposide—Sweating—Doxorubicin—peripheral nervous system neoplasm	2.52e-05	0.000785	CcSEcCtD
Teniposide—Rash—Vincristine—peripheral nervous system neoplasm	2.52e-05	0.000784	CcSEcCtD
Teniposide—Dermatitis—Vincristine—peripheral nervous system neoplasm	2.52e-05	0.000783	CcSEcCtD
Teniposide—Headache—Vincristine—peripheral nervous system neoplasm	2.5e-05	0.000779	CcSEcCtD
Teniposide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	2.48e-05	0.00228	CbGpPWpGaD
Teniposide—Nausea—Alitretinoin—peripheral nervous system neoplasm	2.46e-05	0.000767	CcSEcCtD
Teniposide—NCOA1—Metabolism—COX2—peripheral nervous system neoplasm	2.46e-05	0.00226	CbGpPWpGaD
Teniposide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	2.42e-05	0.000752	CcSEcCtD
Teniposide—NCOA3—Developmental Biology—MET—peripheral nervous system neoplasm	2.39e-05	0.0022	CbGpPWpGaD
Teniposide—TOP2A—Vinorelbine—Vincristine—peripheral nervous system neoplasm	2.39e-05	0.0237	CbGdCrCtD
Teniposide—TOP2A—Podofilox—Etoposide—peripheral nervous system neoplasm	2.39e-05	0.0237	CbGdCrCtD
Teniposide—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	2.39e-05	0.000742	CcSEcCtD
Teniposide—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	2.38e-05	0.000739	CcSEcCtD
Teniposide—Nausea—Vincristine—peripheral nervous system neoplasm	2.37e-05	0.000739	CcSEcCtD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—HRAS—peripheral nervous system neoplasm	2.37e-05	0.00218	CbGpPWpGaD
Teniposide—Flushing—Epirubicin—peripheral nervous system neoplasm	2.37e-05	0.000738	CcSEcCtD
Teniposide—ABCG2—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	2.37e-05	0.00217	CbGpPWpGaD
Teniposide—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	2.36e-05	0.000735	CcSEcCtD
Teniposide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	2.36e-05	0.00217	CbGpPWpGaD
Teniposide—Asthenia—Etoposide—peripheral nervous system neoplasm	2.32e-05	0.000723	CcSEcCtD
Teniposide—Chills—Epirubicin—peripheral nervous system neoplasm	2.29e-05	0.000713	CcSEcCtD
Teniposide—Pruritus—Etoposide—peripheral nervous system neoplasm	2.29e-05	0.000713	CcSEcCtD
Teniposide—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	2.28e-05	0.00071	CcSEcCtD
Teniposide—TOP2A—Mitotic G1-G1/S phases—CDKN2A—peripheral nervous system neoplasm	2.26e-05	0.00208	CbGpPWpGaD
Teniposide—Alopecia—Epirubicin—peripheral nervous system neoplasm	2.26e-05	0.000702	CcSEcCtD
Teniposide—Vomiting—Cisplatin—peripheral nervous system neoplasm	2.25e-05	0.000699	CcSEcCtD
Teniposide—NCOA1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.24e-05	0.00205	CbGpPWpGaD
Teniposide—Rash—Cisplatin—peripheral nervous system neoplasm	2.23e-05	0.000693	CcSEcCtD
Teniposide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	2.23e-05	0.000693	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	2.22e-05	0.00204	CbGpPWpGaD
Teniposide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	2.22e-05	0.000689	CcSEcCtD
Teniposide—NCOA3—Developmental Biology—PTPN11—peripheral nervous system neoplasm	2.21e-05	0.00203	CbGpPWpGaD
Teniposide—NCOA1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.19e-05	0.00202	CbGpPWpGaD
Teniposide—Flushing—Doxorubicin—peripheral nervous system neoplasm	2.19e-05	0.000682	CcSEcCtD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	2.18e-05	0.002	CbGpPWpGaD
Teniposide—Chills—Doxorubicin—peripheral nervous system neoplasm	2.12e-05	0.00066	CcSEcCtD
Teniposide—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	2.11e-05	0.000657	CcSEcCtD
Teniposide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	2.1e-05	0.00193	CbGpPWpGaD
Teniposide—Nausea—Cisplatin—peripheral nervous system neoplasm	2.1e-05	0.000653	CcSEcCtD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—AKT1—peripheral nervous system neoplasm	2.1e-05	0.00193	CbGpPWpGaD
Teniposide—Alopecia—Doxorubicin—peripheral nervous system neoplasm	2.09e-05	0.00065	CcSEcCtD
Teniposide—Vomiting—Etoposide—peripheral nervous system neoplasm	2.06e-05	0.00064	CcSEcCtD
Teniposide—Anaemia—Epirubicin—peripheral nervous system neoplasm	2.06e-05	0.000639	CcSEcCtD
Teniposide—Agitation—Epirubicin—peripheral nervous system neoplasm	2.04e-05	0.000636	CcSEcCtD
Teniposide—Rash—Etoposide—peripheral nervous system neoplasm	2.04e-05	0.000635	CcSEcCtD
Teniposide—Dermatitis—Etoposide—peripheral nervous system neoplasm	2.04e-05	0.000635	CcSEcCtD
Teniposide—Headache—Etoposide—peripheral nervous system neoplasm	2.03e-05	0.000631	CcSEcCtD
Teniposide—Leukopenia—Epirubicin—peripheral nervous system neoplasm	1.99e-05	0.000619	CcSEcCtD
Teniposide—NCOA1—Developmental Biology—MET—peripheral nervous system neoplasm	1.98e-05	0.00182	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—ENO2—peripheral nervous system neoplasm	1.95e-05	0.00179	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	1.93e-05	0.00177	CbGpPWpGaD
Teniposide—Nausea—Etoposide—peripheral nervous system neoplasm	1.92e-05	0.000598	CcSEcCtD
Teniposide—Hypertension—Epirubicin—peripheral nervous system neoplasm	1.92e-05	0.000597	CcSEcCtD
Teniposide—Anaemia—Doxorubicin—peripheral nervous system neoplasm	1.9e-05	0.000592	CcSEcCtD
Teniposide—Chest pain—Epirubicin—peripheral nervous system neoplasm	1.89e-05	0.000589	CcSEcCtD
Teniposide—Agitation—Doxorubicin—peripheral nervous system neoplasm	1.89e-05	0.000588	CcSEcCtD
Teniposide—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	1.84e-05	0.000573	CcSEcCtD
Teniposide—Confusional state—Epirubicin—peripheral nervous system neoplasm	1.83e-05	0.000569	CcSEcCtD
Teniposide—NCOA1—Developmental Biology—PTPN11—peripheral nervous system neoplasm	1.83e-05	0.00168	CbGpPWpGaD
Teniposide—Oedema—Epirubicin—peripheral nervous system neoplasm	1.82e-05	0.000565	CcSEcCtD
Teniposide—Infection—Epirubicin—peripheral nervous system neoplasm	1.8e-05	0.000561	CcSEcCtD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	1.79e-05	0.00164	CbGpPWpGaD
Teniposide—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	1.78e-05	0.000553	CcSEcCtD
Teniposide—Hypertension—Doxorubicin—peripheral nervous system neoplasm	1.78e-05	0.000553	CcSEcCtD
Teniposide—Tachycardia—Epirubicin—peripheral nervous system neoplasm	1.77e-05	0.000551	CcSEcCtD
Teniposide—ABCG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.76e-05	0.00162	CbGpPWpGaD
Teniposide—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	1.75e-05	0.000546	CcSEcCtD
Teniposide—Chest pain—Doxorubicin—peripheral nervous system neoplasm	1.75e-05	0.000545	CcSEcCtD
Teniposide—NCOA3—Developmental Biology—ERBB2—peripheral nervous system neoplasm	1.75e-05	0.00161	CbGpPWpGaD
Teniposide—Anorexia—Epirubicin—peripheral nervous system neoplasm	1.73e-05	0.000538	CcSEcCtD
Teniposide—TOP2A—Cell Cycle—AURKA—peripheral nervous system neoplasm	1.73e-05	0.00159	CbGpPWpGaD
Teniposide—Hypotension—Epirubicin—peripheral nervous system neoplasm	1.7e-05	0.000528	CcSEcCtD
Teniposide—ABCG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.7e-05	0.00156	CbGpPWpGaD
Teniposide—Confusional state—Doxorubicin—peripheral nervous system neoplasm	1.69e-05	0.000527	CcSEcCtD
Teniposide—Oedema—Doxorubicin—peripheral nervous system neoplasm	1.68e-05	0.000522	CcSEcCtD
Teniposide—Infection—Doxorubicin—peripheral nervous system neoplasm	1.67e-05	0.000519	CcSEcCtD
Teniposide—NCOA3—Metabolism—BCHE—peripheral nervous system neoplasm	1.65e-05	0.00152	CbGpPWpGaD
Teniposide—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	1.64e-05	0.000512	CcSEcCtD
Teniposide—TOP2A—Vinblastine—Vincristine—peripheral nervous system neoplasm	1.64e-05	0.0163	CbGdCrCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.64e-05	0.00151	CbGpPWpGaD
Teniposide—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	1.64e-05	0.00051	CcSEcCtD
Teniposide—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	1.62e-05	0.000505	CcSEcCtD
Teniposide—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	1.62e-05	0.000503	CcSEcCtD
Teniposide—NCOA1—Metabolism—ENO2—peripheral nervous system neoplasm	1.61e-05	0.00148	CbGpPWpGaD
Teniposide—Anorexia—Doxorubicin—peripheral nervous system neoplasm	1.6e-05	0.000498	CcSEcCtD
Teniposide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	1.58e-05	0.000491	CcSEcCtD
Teniposide—NCOA3—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.57e-05	0.00145	CbGpPWpGaD
Teniposide—Hypotension—Doxorubicin—peripheral nervous system neoplasm	1.57e-05	0.000488	CcSEcCtD
Teniposide—NCOA3—Metabolism—TH—peripheral nervous system neoplasm	1.55e-05	0.00142	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CHEK2—peripheral nervous system neoplasm	1.54e-05	0.00142	CbGpPWpGaD
Teniposide—TOP2A—Mitotic G1-G1/S phases—MYC—peripheral nervous system neoplasm	1.53e-05	0.00141	CbGpPWpGaD
Teniposide—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	1.5e-05	0.000466	CcSEcCtD
Teniposide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	1.5e-05	0.000465	CcSEcCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.49e-05	0.00137	CbGpPWpGaD
Teniposide—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	1.48e-05	0.000462	CcSEcCtD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.48e-05	0.00136	CbGpPWpGaD
Teniposide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	1.46e-05	0.000454	CcSEcCtD
Teniposide—NCOA1—Developmental Biology—ERBB2—peripheral nervous system neoplasm	1.45e-05	0.00133	CbGpPWpGaD
Teniposide—Urticaria—Epirubicin—peripheral nervous system neoplasm	1.44e-05	0.000449	CcSEcCtD
Teniposide—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	1.44e-05	0.000446	CcSEcCtD
Teniposide—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	1.44e-05	0.000446	CcSEcCtD
Teniposide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	1.38e-05	0.000431	CcSEcCtD
Teniposide—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	1.37e-05	0.000427	CcSEcCtD
Teniposide—NCOA1—Metabolism—BCHE—peripheral nervous system neoplasm	1.36e-05	0.00125	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.35e-05	0.00124	CbGpPWpGaD
Teniposide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	1.34e-05	0.000416	CcSEcCtD
Teniposide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	1.33e-05	0.000415	CcSEcCtD
Teniposide—NCOA3—Developmental Biology—NRAS—peripheral nervous system neoplasm	1.33e-05	0.00122	CbGpPWpGaD
Teniposide—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	1.33e-05	0.000413	CcSEcCtD
Teniposide—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	1.33e-05	0.000413	CcSEcCtD
Teniposide—Asthenia—Epirubicin—peripheral nervous system neoplasm	1.3e-05	0.000405	CcSEcCtD
Teniposide—NCOA1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.3e-05	0.0012	CbGpPWpGaD
Teniposide—Pruritus—Epirubicin—peripheral nervous system neoplasm	1.28e-05	0.000399	CcSEcCtD
Teniposide—NCOA1—Metabolism—TH—peripheral nervous system neoplasm	1.28e-05	0.00118	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—GNAS—peripheral nervous system neoplasm	1.27e-05	0.00116	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.26e-05	0.00116	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	1.25e-05	0.00115	CbGpPWpGaD
Teniposide—TOP2A—Daunorubicin—Epirubicin—peripheral nervous system neoplasm	1.25e-05	0.0124	CbGdCrCtD
Teniposide—TOP2A—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	1.25e-05	0.0124	CbGdCrCtD
Teniposide—TOP2A—Idarubicin—Epirubicin—peripheral nervous system neoplasm	1.25e-05	0.0124	CbGdCrCtD
Teniposide—NCOA3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.24e-05	0.00114	CbGpPWpGaD
Teniposide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	1.24e-05	0.000386	CcSEcCtD
Teniposide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	1.24e-05	0.000385	CcSEcCtD
Teniposide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	1.21e-05	0.000375	CcSEcCtD
Teniposide—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.19e-05	0.00109	CbGpPWpGaD
Teniposide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	1.19e-05	0.00037	CcSEcCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.16e-05	0.00107	CbGpPWpGaD
Teniposide—Vomiting—Epirubicin—peripheral nervous system neoplasm	1.15e-05	0.000359	CcSEcCtD
Teniposide—TOP2A—Daunorubicin—Doxorubicin—peripheral nervous system neoplasm	1.15e-05	0.0114	CbGdCrCtD
Teniposide—TOP2A—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	1.15e-05	0.0114	CbGdCrCtD
Teniposide—TOP2A—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	1.15e-05	0.0114	CbGdCrCtD
Teniposide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	1.15e-05	0.000357	CcSEcCtD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.15e-05	0.00105	CbGpPWpGaD
Teniposide—Rash—Epirubicin—peripheral nervous system neoplasm	1.14e-05	0.000356	CcSEcCtD
Teniposide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	1.14e-05	0.000356	CcSEcCtD
Teniposide—Headache—Epirubicin—peripheral nervous system neoplasm	1.14e-05	0.000354	CcSEcCtD
Teniposide—TOP2A—Cell Cycle—BIRC5—peripheral nervous system neoplasm	1.12e-05	0.00103	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—NRAS—peripheral nervous system neoplasm	1.1e-05	0.00101	CbGpPWpGaD
Teniposide—NCOA1—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	1.09e-05	0.001	CbGpPWpGaD
Teniposide—Nausea—Epirubicin—peripheral nervous system neoplasm	1.08e-05	0.000335	CcSEcCtD
Teniposide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	1.07e-05	0.000332	CcSEcCtD
Teniposide—Rash—Doxorubicin—peripheral nervous system neoplasm	1.06e-05	0.000329	CcSEcCtD
Teniposide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	1.06e-05	0.000329	CcSEcCtD
Teniposide—Headache—Doxorubicin—peripheral nervous system neoplasm	1.05e-05	0.000327	CcSEcCtD
Teniposide—NCOA1—Metabolism—GNAS—peripheral nervous system neoplasm	1.05e-05	0.000962	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.03e-05	0.000944	CbGpPWpGaD
Teniposide—Nausea—Doxorubicin—peripheral nervous system neoplasm	9.98e-06	0.00031	CcSEcCtD
Teniposide—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.76e-06	0.000896	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—HRAS—peripheral nervous system neoplasm	9.73e-06	0.000894	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	9.54e-06	0.000876	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	9.16e-06	0.000841	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	8.97e-06	0.000824	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.9e-06	0.000817	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	8.6e-06	0.00079	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—AKT1—peripheral nervous system neoplasm	8.59e-06	0.000789	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.53e-06	0.000783	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	8.3e-06	0.000762	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	8.25e-06	0.000758	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	8.06e-06	0.00074	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—HRAS—peripheral nervous system neoplasm	8.05e-06	0.000739	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	7.94e-06	0.000729	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	7.42e-06	0.000682	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	7.22e-06	0.000663	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—AKT1—peripheral nervous system neoplasm	7.11e-06	0.000653	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	7.08e-06	0.000651	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.59e-06	0.000606	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	6.17e-06	0.000566	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.01e-06	0.000552	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	5.91e-06	0.000543	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.87e-06	0.000539	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	5.69e-06	0.000523	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	5.62e-06	0.000517	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.48e-06	0.000503	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—MYC—peripheral nervous system neoplasm	5.24e-06	0.000482	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	5.21e-06	0.000479	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—MYC—peripheral nervous system neoplasm	5.03e-06	0.000462	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5e-06	0.000459	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	4.77e-06	0.000438	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	4.57e-06	0.00042	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	4.4e-06	0.000405	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	4.4e-06	0.000404	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	4.35e-06	0.000399	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.2e-06	0.000386	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	4.17e-06	0.000383	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	4.14e-06	0.00038	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—TP53—peripheral nervous system neoplasm	4.13e-06	0.000379	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	4.01e-06	0.000368	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.96e-06	0.000364	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	3.74e-06	0.000343	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—AKT1—peripheral nervous system neoplasm	3.64e-06	0.000334	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—AKT1—peripheral nervous system neoplasm	3.42e-06	0.000314	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	3.38e-06	0.000311	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	3.32e-06	0.000305	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	3.16e-06	0.00029	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.01e-06	0.000277	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	2.97e-06	0.000273	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	2.89e-06	0.000265	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	2.87e-06	0.000263	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—AKT1—peripheral nervous system neoplasm	2.83e-06	0.00026	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	2.75e-06	0.000252	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	2.65e-06	0.000243	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	2.63e-06	0.000242	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	2.44e-06	0.000224	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	2.42e-06	0.000223	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	2.38e-06	0.000218	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.33e-06	0.000214	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	2.29e-06	0.000211	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	2.22e-06	0.000204	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.12e-06	0.000195	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	2.09e-06	0.000192	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	1.87e-06	0.000172	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	1.84e-06	0.000169	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.74e-06	0.00016	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	1.71e-06	0.000157	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	1.68e-06	0.000154	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.47e-06	0.000135	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.4e-06	0.000129	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.38e-06	0.000127	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.13e-06	0.000103	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.11e-06	0.000102	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	9.13e-07	8.38e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	6.54e-07	6.01e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	5.05e-07	4.64e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	4.61e-07	4.23e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	3.04e-07	2.79e-05	CbGpPWpGaD
